New study points to a better way to ward off asthma triggers

While quick-acting inhalers and medications can reduce inflammation during an asthma attack, people with asthma have few tools to prevent the next attack from coming. Now researchers at La Jolla Institute for Immunology (LJI) have discovered that...
11-Nov-2020 3:25 PM EST Add to Favorites

Fighting Zika? Call in the T cells

In a new Science Advances study, Shresta and her colleagues at LJI report that the immune system's T cells have the power to prevent Zika infection in mice. This finding suggests that effective Zika vaccines need to activate T cells to work...
30-Oct-2020 1:35 PM EDT Add to Favorites

Diabetes researchers spot dangerous T cells in the pancreas—even in healthy people

It's long been thought that having "autoreactive" T cells in the pancreas was a sure sign of type 1 diabetes. Yet a new study led by scientists at La Jolla Institute for Immunology (LJI) shows that even healthy people have these cells lurking in the...
12-Oct-2020 4:25 PM EDT Add to Favorites

Every COVID-19 case seems different. These scientists want to know why.

A new international study led by scientists at La Jolla Institute for Immunology (LJI), The University of Liverpool and the University of Southampton is the first to give a detailed snapshot of how the body's CD4+ T cells respond to the SARS-CoV-2...
6-Oct-2020 2:40 PM EDT Add to Favorites

A step toward helping patients breathe deeply

In a new study, researchers at La Jolla Institute for Immunology (LJI) report that a protein called TL1A drives fibrosis in several mouse models, triggering tissue remodeling, and making it harder for lungs and airways to function normally.
24-Sep-2020 3:35 PM EDT Add to Favorites

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of the evidence pointing to a much bigger role for T cells than...
16-Sep-2020 2:55 PM EDT Add to Favorites

LJI scientists receive $3.5 million to investigate role of immune cells in Parkinson's disease

Scientists at the La Jolla Institute for Immunology (LJI) have received $3.5 million as part of a team award from Aligning Science Across Parkinson’s (ASAP) to support a three-year study into how immune cells may contribute to Parkinson's disease.
15-Sep-2020 1:45 PM EDT Add to Favorites

Beating HIV and COVID-19 may depend on tweaking vaccine molecules

In a new Immunity study, researchers at La Jolla Institute for Immunology (LJI) show that one way to improve the body's immune response to vaccines is to factor in antigen valency. Valency refers to the number of antibody binding sites on an antigen.
27-Aug-2020 3:45 PM EDT Add to Favorites

See All News